Comparing two surgery methods for mid and lower rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares a new surgery method that uses multiple technologies to remove rectal cancer more precisely versus the standard surgery. It is for people with middle or lower rectal cancer that hasn't spread, and it may help improve outcomes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old.
- A biopsy must have confirmed you have rectal adenocarcinoma (a common type of rectal cancer).
- An MRI must show the cancer is in the middle to lower part of the rectum (below your belly button line).
- You should not have cancer that has spread to other organs (no distant metastasis on CT/MRI).
- Your overall health should be good enough for surgery, with an ASA score of 3 or lower.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This study compares two ways of performing rectal cancer surgery: robotic surgery and a newer technique called TaTME (transanal total mesorectal excision). It aims to see which approach has better outcomes for patients. If you're having surgery for rectal cancer, this trial might help you get access to advanced surgical options.
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
This study tests a new combination of treatment before surgery for high-risk rectal cancer. It combines a shorter course of radiation with chemotherapy and immunotherapy (which helps your immune system fight cancer) to see if it shrinks the tumor and improves outcomes.
This study compares two ways of reconnecting the intestine after rectal cancer surgery. It looks at a newer method called TTSS against the standard double-stapled technique.
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.